Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

Background Data on global trends in resistance to antituberculosis drugs are lacking. Methods We expanded the survey conducted by the World Health Organization and the International Union against Tuberculosis and Lung Disease to assess trends in resistance to antituberculosis drugs in countries on six continents. We obtained data using standard protocols from ongoing surveillance or from surveys of representative samples of all patients with tuberculosis. The standard sampling techniques distinguished between new and previously treated patients, and laboratory performance was checked by means of an international program of quality assurance. Results Between 1996 and 1999, patients in 58 geographic sites were surveyed; 28 sites provided data for at least two years. For patients with newly diagnosed tuberculosis, the frequency of resistance to at least one antituberculosis drug ranged from 1.7 percent in Uruguay to 36.9 percent in Estonia (median, 10.7 percent). The prevalence increased in Estonia, from 28....

[1]  A. Harries,et al.  Tuberculosis and HIV: current status in Africa. , 1997, AIDS.

[2]  K. Castro,et al.  Completion of tuberculosis therapy for patients reported in the United States in 1993. , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[3]  M. Iseman,et al.  PITFALLS IN THE CARE OF PATIENTS WITH TUBERCULOSIS: COMMON ERRORS AND THEIR ASSOCIATION WITH THE ACQUISITION OF DRUG RESISTANCE , 1993, JAMA.

[4]  T. S. van der Werf,et al.  Antituberculosis-drug resistance. , 1998, The New England journal of medicine.

[5]  D. Mitchison,et al.  Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. , 2015, The American review of respiratory disease.

[6]  R. Lumb,et al.  Tuberculosis in Australia, 1989–1992: Bacteriologlcally confirmed cases and drug resistance , 1995, The Medical journal of Australia.

[7]  Christopher Dye,et al.  Assessment of worldwide tuberculosis control , 1997, The Lancet.

[8]  Mohammad Mustafizur Rahman,et al.  Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing. , 1997, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[9]  C. Dye,et al.  Rational 'DOTS plus' for the control of MDR-TB. , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[10]  C. Dye,et al.  Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. , 1999, JAMA.

[11]  H L Rieder,et al.  Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. , 1998, The New England journal of medicine.

[12]  Lung Disease,et al.  Anti-tuberculosis drug resistance in the world : the WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance , 1997 .

[13]  S. Glismann,et al.  Results from 8 yrs of susceptibility testing of clinical Mycobacterium tuberculosis isolates in Denmark , 2000 .

[14]  J. Caminero,et al.  Towards elimination of tuberculosis in a low income country: the experience of Cuba, 1962–97 , 2000, Thorax.

[15]  Chaisson Re,et al.  DOTS and drug resistance: a silver lining to a darkening cloud. , 1999 .

[16]  Christopher Dye,et al.  Global Burden of Tuberculosis: Estimated Incidence, Prevalence, and Mortality by Country , 1999 .

[17]  C. Dye,et al.  Will tuberculosis become resistant to all antibiotics? , 2001, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[18]  H. Magnussen,et al.  Drug-resistant tuberculosis in northern Germany: a retrospective hospital-based study of 1,055 patients from 1984 until 1993. , 1995, The European respiratory journal.

[19]  A. Khomenko,et al.  Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. , 2000, JAMA.

[20]  De Cock Km,et al.  Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection. , 1999 .

[21]  Dean T. Jamison,et al.  World development report 1993 : investing in health , 1993 .

[22]  C. Dye,et al.  Progress in global tuberculosis control 1995-1996, with emphasis on 22 high-incidence countries. Global Monitoring and Surveillance Project. , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[23]  M. Mwasekaga,et al.  Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana. , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[24]  A. Khomenko,et al.  Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. , 1969, Bulletin of the World Health Organization.

[25]  Sang-Do Lee,et al.  Cohort analyses of the treatment of smear-positive pulmonary tuberculosis patients under programme conditions in Korea, 1983-1994. , 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[26]  A. Trébucq,et al.  Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to antituberculosis drugs in Benin after 12 years of short-course chemotherapy. , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[27]  T. Frieden,et al.  Tuberculosis in New York City--turning the tide. , 1995, The New England journal of medicine.